InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.04
(
0.14%
)
Bitcoin
57,330.82
(
-4.70%
)
Post# of 48820
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ProfitScout

Send PM Follow Ignore
Followers 179
Posts 24822
Boards Moderated 17
Alias Born 04/03/2002

ProfitScout

Re: None

Thursday, 12/28/2023 12:48:26 PM

Thursday, December 28, 2023 12:48:26 PM

Post# of 48820
$RNXT is addressing the under-served area of oncology today such as bile duct cancer. Their collaboration with The University of Oklahoma should be of high value in making progress in this key medical industry niche that can help where it is really needed.

RenovoRx Engaged Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer
https://www.businesswire.com/news/home/20231221037143/en/RenovoRx-Engages-Oklahoma-University-OU-Health-as-First-Clinical-Site-in-Preparation-for-the-Pivotal-Phase-III-CouGar-Clinical-Trial-in-Bile-Duct-Cancer?utm_campaign=shareaholic&utm_medium=twitter&utm_source=socialnetwork
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up